4-S-EtdU

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug Name4-S-EtdU
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsVaricella Zoster Virus InfectionHerpes SimplexEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsVaricella Zoster Virus InfectionHerpes SimplexEpstein-Barr Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A